Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
MGC Pharmaceuticals (MGCLF)
OTHER OTC:MGCLF
RESEARCH TOOLSreports
MGC Pharmaceuticals (MGCLF) Stock Price & Analysis
28 Followers
MGCLF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.20 - $1.40
Previous Close$0.25
Volume356.00
Average Volume (3M)1.04K
Market Cap
$11.36M
Enterprise Value$11.17M
Total Cash (Recent Filing)AU$239.82K
Total Debt (Recent Filing)AU$575.14K
Price to Earnings (P/E)-0.1
Beta-1.27
Next Earnings
Aug 28, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.41
Shares Outstanding3,198,519
10 Day Avg. Volume187
30 Day Avg. Volume1,037
Standard Deviation66.04
R-Squared0.04
Alpha6.00
Financial Highlights & Ratios
Price to Book (P/B)-139.36
Price to Sales (P/S)3.76
Price to Cash Flow (P/CF)-23.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
MGC Pharmaceuticals News
PremiumCompany Announcements
Argent BioPharma Grants Options to Executives
PremiumCompany Announcements
Argent BioPharma Announces Corporate Updates
PremiumCompany Announcements
Argent Biopharma Issues New Employee Incentive Options
PremiumCompany Announcements
Argent Biopharma Options Expire UnexercisedMGCLF FAQ
What was MGC Pharmaceuticals’s price range in the past 12 months?
MGC Pharmaceuticals lowest stock price was $0.20 and its highest was $1.40 in the past 12 months.
What is MGC Pharmaceuticals’s market cap?
Currently, no data Available
When is MGC Pharmaceuticals’s upcoming earnings report date?
MGC Pharmaceuticals’s upcoming earnings report date is Aug 28, 2024 which is in 115 days.
How were MGC Pharmaceuticals’s earnings last quarter?
MGC Pharmaceuticals released its earnings results on Feb 29, 2024. The company reported -$20.011 earnings per share for the quarter, missing the consensus estimate of N/A by -$20.011.
Is MGC Pharmaceuticals overvalued?
According to Wall Street analysts MGC Pharmaceuticals’s price is currently Overvalued.
Does MGC Pharmaceuticals pay dividends?
MGC Pharmaceuticals does not currently pay dividends.
What is MGC Pharmaceuticals’s EPS estimate?
MGC Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MGC Pharmaceuticals have?
MGC Pharmaceuticals has 45,280,200 shares outstanding.
What happened to MGC Pharmaceuticals’s price movement after its last earnings report?
MGC Pharmaceuticals reported an EPS of -$20.011 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 11.538%.
Which hedge fund is a major shareholder of MGC Pharmaceuticals?
Currently, no hedge funds are holding shares in MGCLF
---
MGC Pharmaceuticals Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bearish
MGCLF Sentiment 85%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $1.6K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
14.42%
Trailing 12-Months
Company Description
MGC Pharmaceuticals
MGC Pharmaceuticals Ltd is a European-based specialist Medical Cannabis company, in Phytocannabinoid-based medicine within the biopharmaceutical industry. The company's principal business goal is to produces and supply quality Cannabinoid based pharmaceutical products for the emergent medical markets in Europe, North America and Australasia.
---
Technical Analysis
---